Preamble ..........................

Preamble ................................................................................................................................................................................... 5
1. Introduction .......................................................................................................................................................................... 9
1.1. Methodology and Evidence Review ............................................................................................................................. 9
1.2. Organization of the Writing Committee ....................................................................................................................... 9
1.3. Document Review and Approval .................................................................................................................................. 9
1.4. Scope of the Guideline ............................................................................................................................................... 10
2. General Principles .............................................................................................................................................................. 11
2.1. Evaluation of the Patient With Suspected VHD ......................................................................................................... 11
2.2. Definitions of Severity of Valve Disease ................................................................................................................... 11
2.3. Diagnostic TestingDiagnosis and Follow-Up: Recommendations ......................................................................... 12
2.4. Basic Principles of Medical Therapy: Recommendations .......................................................................................... 13
2.5. Evaluation of Surgical and Interventional Risk .......................................................................................................... 14
2.6. The Heart Valve Team and Heart Valve Centers of Excellence: Recommendations ................................................. 14
3. Aortic Stenosis: Recommendations .................................................................................................................................... 16
3.1. Stages of Valvular AS ................................................................................................................................................ 16
3.2. Diagnosis and Follow-Up ........................................................................................................................................... 19
3.3. Medical Therapy ......................................................................................................................................................... 19
3.4. Timing of Intervention ................................................................................................................................................ 19
3.5. Choice of Intervention ................................................................................................................................................ 22
4. Aortic Regurgitation: Recommendations ........................................................................................................................... 23
4.1. Stages of Chronic Aortic Regurgitation ...................................................................................................................... 23
4.2. Diagnosis and Follow-Up ........................................................................................................................................... 27
4.3. Medical Therapy ......................................................................................................................................................... 27
4.4. Timing of Intervention ................................................................................................................................................ 27
5. Bicuspid Aortic Valve and Aortopathy: Recommendations .............................................................................................. 29
5.1. Diagnosis and Follow-Up ........................................................................................................................................... 29
5.2. Intervention ................................................................................................................................................................. 29
6. Mitral Stenosis: Recommendations .................................................................................................................................... 29
6.1. Stages of MS ............................................................................................................................................................... 29
6.2. Diagnosis and Follow-Up .................................................

ผลลัพธ์ (ไทย) 1:

Preamble ................................................................................................................................................................................... 51. Introduction .......................................................................................................................................................................... 91.1. Methodology and Evidence Review ............................................................................................................................. 91.2. องค์กรคณะกรรมการเขียน... 91.3. Document Review and Approval .................................................................................................................................. 91.4. Scope of the Guideline ............................................................................................................................................... 102. General Principles .............................................................................................................................................................. 112.1. การประเมินผู้ป่วยสงสัย VHD ... 112.2. นิยามของความรุนแรงของโรคลิ้น... 112.3. TestingDiagnosis วินิจฉัยและติดตามผล: คำแนะนำ... 122.4. พื้นฐานหลักของการรักษาทางการแพทย์: คำแนะนำ... 132.5. การประเมินผลความเสี่ยงผ่าตัด และรักษา... 142.6. หัวใจทีมงานวาล์วและวาล์วหัวใจศูนย์กระดูก: คำแนะนำ... 143. Aortic Stenosis: Recommendations .................................................................................................................................... 163.1. Stages of Valvular AS ................................................................................................................................................ 163.2. Diagnosis and Follow-Up ........................................................................................................................................... 193.3. Medical Therapy ......................................................................................................................................................... 193.4. Timing of Intervention ................................................................................................................................................ 193.5. Choice of Intervention ................................................................................................................................................ 224. เอออร์ตาส่วนสำรอก: คำแนะนำ... 234.1. ขั้นตอนของการสำรอกเอออร์ตาส่วนที่เรื้อรัง... 234.2. Diagnosis and Follow-Up ........................................................................................................................................... 274.3. Medical Therapy ......................................................................................................................................................... 274.4. Timing of Intervention ................................................................................................................................................ 275. bicuspid เอออร์ตาส่วนวาล์วและ Aortopathy: คำแนะนำ... 295.1. Diagnosis and Follow-Up ........................................................................................................................................... 295.2. Intervention ................................................................................................................................................................. 296. Mitral Stenosis: Recommendations .................................................................................................................................... 296.1. Stages of MS ............................................................................................................................................................... 296.2. การวินิจฉัยและติดตามผล...

ผลลัพธ์ (ไทย) 2:

บทนำ ................................................. .................................................. .................................................. .............................. 5
1. บทนำ ................ .................................................. .................................................. .................................................. .... 9
1.1 วิธีการและการทบทวนหลักฐาน .............................................. .................................................. ............................. 9
1.2 องค์การของคณะกรรมการการเขียน ............................................. .................................................. ........................ 9
1.3 ทบทวนเอกสารและการอนุญาต .............................................. .................................................. .................................. 9
1.4 ขอบเขตของแนวทาง .............................................. .................................................. ............................................... 10
2 หลักการทั่วไป ................................................ .................................................. .................................................. .......... 11
2.1 การประเมินผลของผู้ป่วยด้วย VHD สงสัย ........................................... .................................................. ............ 11
2.2 ความหมายของความรุนแรงของโรควาล์ว ............................................ .................................................. ..................... 11
2.3 วินิจฉัยTestingDiagnosisและการติดตามผล: คำแนะนำ ........................................ ................................. 12
2.4 หลักการพื้นฐานของการบำบัดทางการแพทย์: คำแนะนำ ........................................... ............................................... 13
2.5 การประเมินความเสี่ยงและการผ่าตัด Interventional ............................................ .................................................. ............ 14
2.6 หัวใจวาล์วทีมและหัวใจศูนย์แห่งความเป็นเลิศวาล์ว: คำแนะนำ ...................................... ........... 14
3. หลอดเลือดตีบ: คำแนะนำ ................................ .................................................. .................................................. 16
3.1 ขั้นตอนของลิ้น AS .............................................. .................................................. ................................................ 16
3.2 . การวินิจฉัยและการติดตาม ............................................. .................................................. ............................................ 19
3.3 การรักษาทางการแพทย์ ................................................ .................................................. .................................................. ..... 19
3.4 ระยะเวลาของการแทรกแซง ............................................... .................................................. ............................................... 19
3.5 ทางเลือกของการแทรกแซง ............................................... .................................................. ............................................... 22
4 สำรอกหลอดเลือด: คำแนะนำ .............................................. .................................................. ........................... 23
4.1 ขั้นตอนของการสำรอกเลือดเรื้อรัง ............................................. .................................................. ....................... 23
4.2 การวินิจฉัยและการติดตาม ............................................. .................................................. ............................................ 27
4.3 การรักษาทางการแพทย์ ................................................ .................................................. .................................................. ..... 27
4.4 ระยะเวลาของการแทรกแซง ............................................... .................................................. ............................................... 27
5 สองแฉก Aortic วาล์วและ Aortopathy: คำแนะนำ ........................................... .................................................. . 29
5.1 การวินิจฉัยและการติดตาม ............................................. .................................................. ............................................ 29
5.2 การแทรกแซง ................................................. .................................................. .................................................. ............ 29
6. Mitral ตีบ: คำแนะนำ ............................... .................................................. .................................................. . 29
6.1 ขั้นตอนของ MS ............................................... .................................................. .................................................. ............ 29
6.2 การวินิจฉัยและการติดตาม ............................................. ....

ผลลัพธ์ (ไทย) 3:

คำนำ ................................................................................................................................................................................... 51 . แนะนำ .......................................................................................................................................................................... 91.1 . วิธีการและ ............................................................................................................................. ตรวจสอบหลักฐาน 91.2 องค์กรของคณะกรรมการ ....................................................................................................................... เขียน 91.3 . ตรวจสอบเอกสารและอนุมัติ .................................................................................................................................. 91.4 . ขอบเขตของแนว ............................................................................................................................................... 102 . หลักการ .............................................................................................................................................................. ทั่วไป 112.1 . การประเมินผู้ป่วยที่สงสัย ......................................................................................................... VHD 112.2 . นิยามของความรุนแรงของโรค ................................................................................................................... วาล์ว 112.3 การวินิจฉัยวินิจฉัยและติดตาม ......................................................................... : ข้อเสนอแนะ 12 .2.4 . หลักการพื้นฐานของการรักษาทางการแพทย์ : ข้อเสนอแนะ .......................................................................................... 13 .2.5 การประเมินความเสี่ยงของการผ่าตัดและการรักษา .......................................................................................................... 14 .2.6 หัวใจวาล์วลิ้นหัวใจของทีม และศูนย์ความเป็นเลิศ ................................................. : ข้อเสนอแนะ 14 .3 . หลอดเลือดตีบ : ข้อเสนอแนะ .................................................................................................................................... 163.1 . ขั้นตอนของการเป็น ................................................................................................................................................ ลิ้น 163.2 . การวินิจฉัยและติดตาม ........................................................................................................................................... 19 .3.3 . ......................................................................................................................................................... แพทย์รักษา 19 .3.4 . เวลาของ ................................................................................................................................................ การแทรกแซง 19 .3.5 . จอง ................................................................................................................................................ การแทรกแซง 224 . ........................................................................................................................... aortic regurgitation : ข้อเสนอแนะ 234.1 . ระยะเรื้อรัง aortic regurgitation ...................................................................................................................... 234.2 . การวินิจฉัยและติดตาม ........................................................................................................................................... 274.3 . ......................................................................................................................................................... แพทย์รักษา 274.4 . เวลาของ ................................................................................................................................................ การแทรกแซง 275 . ซุปเปอร์ฟอสเฟต และตีบ : ข้อเสนอแนะ .............................................................................................. 295.1 การวินิจฉัยและติดตาม ........................................................................................................................................... 295.2 . ................................................................................................................................................................. การแทรกแซง 296 . ลิ้นไมตรัลตีบ : ข้อเสนอแนะ .................................................................................................................................... 296.1 . ขั้นตอนของ MS ............................................................................................................................................................... 296.2 . การวินิจฉัยและติดตาม ...............................................